Jeff Aronin has more than 30 years of life science expertise and leadership. As an entrepreneur and scientific visionary, with a focus on addressing unmet patient and societal needs, Mr. Aronin has received U.S. Food and Drug Administration (FDA) approval of nearly a dozen new medicines and technologies and numerous awards throughout his career. His companies are renowned for advancing science, with a record number of breakthroughs helping patients, and economic engines, having created thousands of job opportunities throughout the world. Paragon Biosciences portfolio companies include: Castle Creek Biosciences, CiRC Biosciences, Emalex Biosciences, Evozyne, Harmony Biosciences, Qlarity Imaging, and Skyline Biosciences, and maintains a consistent flow of incubating companies created and supported by the Paragon Innovation Capital™ model.
Outside of Paragon, Mr. Aronin devotes his talents to civic and philanthropic endeavors. As founder and co-chairman of MATTER – a health-technology startup incubator – Mr. Aronin has led one of Chicago’s most remarkable, philanthropic venture-innovation successes, with more than 200 healthcare companies at any one time, more than 60 corporate sponsors, and more than $1 billion in deals since 2015. He is a member of The Commercial Club of Chicago and serves on several corporate and civic boards including Discover Financial Services and The Aspen Institute. As a believer in education as a change agent, Mr. Aronin serves as a mentor to students and young professionals and is a frequent lecturer at the University of Chicago’s Booth School of Business and Northwestern University’s Kellogg School of Business.